Acumen Pharmaceuticals (ABOS) Non-Current Deffered Revenue (2022 - 2023)
Acumen Pharmaceuticals recorded quarterly Non-Current Deffered Revenue of $183000.0 in Q2 2023, down 45.7% quarter-over-quarter from $337000.0 in Q3 2022, and down 23.11% year-over-year from $238000.0 in Q2 2022.
Acumen Pharmaceuticals' Non-Current Deffered Revenue history runs 2 years deep, the most recent figure standing at $183000.0 for Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 225.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Acumen Pharmaceuticals | 164.37 Mn | 35.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 183,000.00 |
| Sep 30, 2022 | 337,000.00 |
| Jun 30, 2022 | 238,000.00 |